Welcome to our dedicated page for Ormat Tech SEC filings (Ticker: ORA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Ormat Technologies filings document the regulatory record for a NYSE-listed renewable energy operating company with common shares traded under ORA. Recent Form 8-K reports furnish operating and financial results, non-GAAP reconciliations, and exhibits tied to quarterly earnings releases.
The filing record also covers material definitive agreements and capital-structure disclosures, including indentures for Series A and Series B convertible senior notes due 2031. Proxy materials address shareholder voting matters, board governance, executive compensation, equity awards, and pay-versus-performance disclosures.
ORMAT TECHNOLOGIES, INC. director Byron G. Wong reported an open-market sale of common stock. On May 13, 2026, he sold 4,500 shares of Ormat common stock at $134.32 per share. After this transaction, Wong directly owned 5,925 shares of Ormat common stock, and no derivative positions were reported in this filing.
ORA filed a Form 144 proposing the sale of restricted common stock by an issuer-affiliated holder. The notice lists proposed disposals of 100 shares with an intended sale date of 05/08/2026 and 477 shares with an intended sale date of 05/08/2025. Timing and cash‑flow treatment are as stated in the filing.
ORA submitted a Form 144 notifying proposed sales of common stock and several equity award types by an affiliate via broker Morgan Stanley Smith Barney LLC. The notice lists a total identifier 17,776 and dollar figure $2,395,227.75, and references 61,451,752 on the cover with an exchange listing of NYSE as of 05/14/2026.
The filing itemizes planned dispositions of equity awards by grant date and type, including Restricted Stock grants (e.g., 1,675 shares dated 05/12/2022, 837 dated 05/12/2024, 4,336 dated 03/01/2026), Stock Appreciation Rights (2,559 dated 05/14/2026), and Performance Shares (6,611 dated 03/21/2026 and 694 dated 03/01/2026).
ORA filing a Form 144 notice relating to proposed sales of common stock on 05/13/2026 through the NYSE. The filing lists 4,500 and several restricted stock lots dated 11/07/2020, 11/04/2021, 11/03/2022, and 11/02/2023 with per-lot counts shown.
The report identifies the broker as Morgan Stanley Smith Barney LLC and notes the security type as Restricted Stock. The filing is a routine notice of intent to sell and does not itself record completed transactions.
ORA: Form 144 notice reporting intended sale of securities. The filing lists securities to be sold on 05/13/2026 on the NYSE, including Common stock, Performance and Restricted Stock (date listed 05/12/2024), and Stock Appreciation Rights (date listed 05/13/2026). The filing records an amount $1,235,387.58 and numeric entries of 9429, 8930, and 499 associated with listed securities.
Ormat Technologies director Dafna Sharir reported a combination of equity vesting and a small share sale. On May 7, 2026, 1,766 Restricted Stock Units vested, converting into the same number of Ormat common shares. On May 11, 2026, she then sold 883 common shares in an open-market transaction at $122.44 per share, executed under a pre-arranged Rule 10b5-1 trading plan adopted on November 18, 2025. Following these transactions, Sharir directly holds 3,140 shares of Ormat common stock.
ORMAT TECHNOLOGIES, INC. director Byron G. Wong acquired 1,766 shares of common stock through the vesting and exercise of Restricted Stock Units. The RSUs, each representing one share of common stock, vested 100% on May 7, 2026, one year after grant. Following this non-cash, compensation-related exercise, Wong directly holds 10,425 shares of Ormat common stock. No open-market purchases or sales were reported in this filing.
ORMAT TECHNOLOGIES, INC. director Stanley Stern reported the vesting and settlement of restricted stock units into common shares. On May 7, 2026, 1,766 Restricted Stock Units vested and were converted into 1,766 shares of common stock. Following this equity-based compensation event, Stern holds 6,627 shares of Ormat common stock directly.
ORMAT TECHNOLOGIES, INC. director Ravit Barniv reported the vesting and exercise of restricted stock units into common shares. On May 7, 2026, 1,766 Restricted Stock Units vested in full on the first anniversary of the grant, and were converted into 1,766 shares of common stock. After this derivative exercise, Barniv directly holds 1,766 shares of Ormat common stock, with no remaining RSU position shown in this filing.
ORMAT TECHNOLOGIES, INC. director Michal Marom reported a routine equity compensation event. On May 7, 2026, 1,766 Restricted Stock Units vested and were exercised into 1,766 shares of common stock at an exercise price of $0.00 per share. Following this conversion, Marom directly owns 4,846 shares of Ormat common stock, and the reported RSU award has been fully settled into shares.